FDA Drug Recalls

Recalls / Class III

Class IIID-1443-2014

Product

VIRACEPT (R) (nelfinavir mesylate) Tablets, 625 mg, 120-count bottle, Rx only, Manufactured by: Agouron Pharmaceuticals, Inc. A Pfizer Company, Distributed by: ViV Healthcare Company, Research Triangle Park, NC 27709 NDC 63010-027-70

Brand name
Viracept
Generic name
Nelfinavir Mesylate
Active ingredient
Nelfinavir Mesylate
Route
Oral
NDCs
63010-010, 63010-027
FDA application
NDA020779
Affected lot / code info
Lot H45241, exp. 11/16

Why it was recalled

Labeling: Incorrect or missing lot and or Exp Date: The bottles were labeled with an incorrect expiry date 11/2016. The correct expiry date is 09/2016.

Recalling firm

Firm
Pfizer Inc.
Manufacturer
AGOURON
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
235 East 42nd Street, N/A, New York, New York 10017-5703

Distribution

Quantity
1200 tablets
Distribution pattern
Nationwide and Puerto Rico

Timeline

Recall initiated
2014-07-08
FDA classified
2014-07-17
Posted by FDA
2014-07-23
Terminated
2015-07-06
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1443-2014. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: Viracept · FDA Drug Recalls